Drug-induced disseminated intravascular coagulation: a pharmacovigilance study on World Health Organization’s database Giulia BonaldoAlberto VaccheriDomenico Motola OriginalPaper 22 May 2020 Pages: 763 - 771
Inflammatory markers in thrombosis associated with primary antiphospholipid syndrome Fernanda T. ArantesBruna M. MazettoFernanda A. Orsi OriginalPaper 27 May 2020 Pages: 772 - 781
Implementation of automatic data extraction from an enterprise database warehouse (EDW) for validating pediatric VTE decision rule: a prospective observational study in a critical care population Rachael F. SchultzAnjali SharathkumarRukhmi Bhat OriginalPaper 11 June 2020 Pages: 782 - 789
In vivo demonstration of microvascular thrombosis in severe COVID-19 Douglas Alexandre do Espírito SantoAnna Cristina Bertoldi LemosCarlos Henrique Miranda Report 13 August 2020 Pages: 790 - 794
How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report Ezio ZanonSamantha PascaPaolo Simioni BriefCommunication 16 July 2020 Pages: 795 - 798
Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic Benjamin MarchandotAntonin TrimailleOlivier Morel ReviewPaper 21 July 2020 Pages: 799 - 808
Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon Panayotis K. VlachakisAnastasios TentolourisIoannis Kanakakis BriefCommunication 30 July 2020 Pages: 809 - 813
Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis Syed Shahzad HasanSam RadfordSyed Tabish Razi Zaidi BriefCommunication Open access 03 August 2020 Pages: 814 - 821
Long lasting hypercoagulability after subclinical COVID-19 Paolo FerroliChiara VillaMorgan Broggi Report 05 August 2020 Pages: 822 - 824
Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19 Yang LiuWeibo GaoJin Lu OriginalPaper Open access 06 August 2020 Pages: 825 - 832
Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis Chiara KesslerHans StrickerMarco Previsdomini Letter to the Editor 14 August 2020 Pages: 833 - 836
Experience of a 40-day (6 week) LMWH treatment for isolated distal deep vein thrombosis Konstantinos AsonitisEkatherina CharvalosCedric Hermans OriginalPaper 18 March 2020 Pages: 837 - 843
Use of apixaban and rivaroxaban in young adults with acute venous thromboembolism: a multi-center retrospective case series Deborah DeCamilloStacy EllsworthGeoffrey D. Barnes OriginalPaper 27 March 2020 Pages: 844 - 848
A stricter control of low-density lipoprotein is necessary for thrombosis reduction in “lower thrombosis risk” patients with atrial fibrillation: a multicenter retrospective cohort study Weizhuo LiuNanqing XiongJian Li OriginalPaper 13 April 2020 Pages: 849 - 857
Residual platelet reactivity, thrombus burden and myocardial reperfusion in patients treated by PCI after successful pre-hospital fibrinolysis compared to primary PCI Vincent RouleLin SchwobFarzin Beygui OriginalPaper 18 April 2020 Pages: 858 - 866
Safety and efficacy of short-term (1 to 3 months) dual antiplatelet therapy in patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials Babikir KheiriTimothy F. SimpsonFiras Zahr OriginalPaper 30 June 2020 Pages: 867 - 873
The role of P2Y12 receptor inhibition in ischemic stroke on microglia, platelets and vascular smooth muscle cells Fengyang LiDan XuYunman Li ReviewPaper 04 April 2020 Pages: 874 - 885
Predictors for layered coronary plaques: an optical coherence tomography study Makoto ArakiTaishi YonetsuIk-Kyung Jang OriginalPaper 18 April 2020 Pages: 886 - 894
Clinical significance of healed plaque detected by optical coherence tomography: a 2-year follow-up study Osamu KuriharaMichele RussoIk-Kyung Jang OriginalPaper 12 May 2020 Pages: 895 - 902
Risk Of Thrombosis In Elderly Immune Primary Trombocytopenic Patients Treated with Thrombopoietin Receptors Agonists Roberto CastelliAntonio GidaroGiorgio Lambertenghi Deliliers Letter to the Editor 28 April 2020 Pages: 903 - 907
Loop-mediated isothermal amplification (LAMP)-based method for detecting factor V Leiden and factor II G20210A common variants Giovanni Luca TisciaDonatella ColaizzoElvira Grandone BriefCommunication 15 June 2020 Pages: 908 - 912
Efficacy and safety of low dose rivaroxaban in patients with coronary heart disease: a systematic review and meta-analysis Safi U. KhanMuhammad Zia KhanEdo Kaluski OriginalPaper 13 April 2020 Pages: 913 - 920
Effect of erroneous body-weight estimation on outcome of thrombolyzed stroke patients Prakash R. PaliwalArvind K. SharmaVijay K. Sharma OriginalPaper 26 April 2020 Pages: 921 - 928
Thrombolysis in massive and submassive pulmonary embolism during pregnancy and the puerperium: a systematic review David RodriguezCarlos Jerjes-SanchezFrancisco Nevarez ReviewPaper 28 April 2020 Pages: 929 - 941
Ticagrelor for the primary prevention of stroke in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials Qi KongXin MaChengbei Hou OriginalPaper 27 March 2020 Pages: 942 - 956
Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey Islam EljilanyAhmed El-BardissyHazem Elewa OriginalPaper Open access 19 April 2020 Pages: 957 - 968
The Impact of platelet–fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease Jae Seok BaeJong-Hwa AhnYoung-Hoon Jeong OriginalPaper 11 April 2020 Pages: 969 - 981
Rivaroxaban-induced hemorrhagic pericardial tamponade in end-stage renal disease Nicole RapistaSauradeep SarkarRahul Chaudhary Letter to the Editor 03 June 2020 Pages: 982 - 983
Acute phase treatment in central retinal artery occlusion: thrombolysis, hyperbaric oxygen therapy or both? Daniel FerreiraCarolina SoaresPedro Castro BriefCommunication 12 March 2020 Pages: 984 - 988
Severe high-molecular-weight kininogen deficiency due to a homozygous c.1456C > T nonsense variant in a large Chinese family Jing YangLiankai FanTienan Zhu BriefCommunication 17 March 2020 Pages: 989 - 994
Low prevalence of JAK2 V617F mutation in patients with thrombosis and normal blood counts: a retrospective impact study Michaël LevrautLaurence LegrosNihal Martis OriginalPaper 07 April 2020 Pages: 995 - 1003
Albumin and bleed risk in rivaroxaban treated patients E. WojakowskiC. CheruvilA. E. Woodruff OriginalPaper 11 April 2020 Pages: 1004 - 1011
Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019 Yoshihiko OgawaToshihiko NagataIwao Gohma Letter to the Editor 11 August 2020 Pages: 1012 - 1014
Differentiating biochemical from clinical heparin resistance in COVID-19 Ton LismanJecko Thachil Letter to the Editor 03 September 2020 Pages: 1015 - 1016